Recent reviews have highlighted conflicting findings regarding the validity of finger flexor strength and endurance tests in sport climbers, often due to small sample sizes and low ecological validity of the tests used. To address these gaps, 185 male and 122 female climbers underwent maximal finger flexor strength, intermittent and continuous finger flexor endurance, and the finger hang tests in a sport-specific setting to determine the predictive and concurrent validity of these tests. The finger hang test showed the strongest relationship to climbing ability for both sexes (R ≈ 0.75). However, despite its widespread use as an endurance test, the finger hang was found to be primarily determined by finger strength, explaining 65% and 80% of the variance in males and females, respectively. Finger strength emerged as the dominant factor, explaining the majority of variance in climbing ability (males 68%; females 64%), followed by intermittent endurance (males 28%; females 34%). These findings emphasize finger strength as the primary predictor of climbing ability and highlight the importance of intermittent endurance testing for assessing climbing-specific endurance of the finger flexors. No significant differences were found between male and female climbers in finger flexor strength and endurance when normalized to body mass.
- MeSH
- Adult MeSH
- Physical Endurance * physiology MeSH
- Mountaineering * physiology MeSH
- Humans MeSH
- Adolescent MeSH
- Young Adult MeSH
- Fingers * physiology MeSH
- Reproducibility of Results MeSH
- Sex Factors MeSH
- Hand Strength physiology MeSH
- Muscle Strength physiology MeSH
- Exercise Test methods MeSH
- Check Tag
- Adult MeSH
- Humans MeSH
- Adolescent MeSH
- Young Adult MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Validation Study MeSH
Hlavným cieľom realizovaného výskumu bolo odhaliť vplyv rôznych foriem hypoxie (akútnej a inter mitentnej) na výkon výkonnostných plavcov. Realizovali sme vstupné a výstupné testovanie v rýchlosti preplávania 50 metrov kraulom (T1), zisťovali počet nádychov pri plávaní 50 metrovej vzdialenosti kraulom (T2) a maximálnej preplávanej vzdialenosti pod vodou na jeden nádych T3. Výskum bol realizovaný na n = 12 výkonnostných plavcoch (4 ženy a 8 mužov), ktorých priemerný vek bol 15,75 roka, priemerná telesná hmotnosť bola 56,2 kg a priemerná telesná výška bola 172,5 cm. Testova nie bolo realizované po 10 minútovom spoločnom rozcvičení a rozplávanie 400 metrovej vzdialenosti ľubovoľným spôsobom a 2 x (15 metrov šprint + 35 metrov vyplávanie). Aplikácie a využívanie hypoxických podmienok prebiehalo v mesiacov február– marec 2024, 3 týždne / 21 dní. Sledovaný probandi boli náhodne rozdelený do 3 súborov, kde VS1 absolvoval plavecký hypoxický kontrolovaný tréning, VS2 absolvoval prerušovaný simulovaný hypoxický tréning pomocou hypoxického generátora „AltitudeTechPortable 2020“ a VS3 absolvoval klasický podnet bez aplikácie experimentálneho pod netu. Výsledky poukazujú na zistenia, že v teste T1 dosiahol najvýraznejšie priemerné zlepšenia VS2 (+ 5,3 %), v teste T2 dosiahol najvýraznejšie zlepšenia VS1 (+ 35,7 %) a v teste T3 sa najviac zlepšil VS1(+14,3 %). Nazáklade výsledkov môžeme konštatovať, že pre plavcov výkonnostnej úrovne sa javí ako najefektívnejšie využívať akútnu hypoxiu v normoxických podmienkach zaraďovaný do plavecke prípravy v jednotlivých obdobiach v dĺžke 3 týždňov a rozsahu 10-15 minút v tréningovej jednotke po rozcvičení a rozplávaní, ideálne v kombinácii s intermitentnou formou hypoxie podľa realizovanej schémy v tomto výskume najmä pre zlepšenie času v najkratších 50 metrových disciplínach.
The main objective of the research was to determine the impact of different forms of hypoxia (acute and intermittent) on the performance of performance swimmers. We realised pre and post-tests in 50-meter freestyle swimming speed (T1), counted the number of breaths taken during 50-meter freestyle swimming (T2), and measured the maximum underwater distance covered in one breath (T3). The study was conducted on a sample of n = 12 performance swimmers (4 females and 8 males), with the average age of 15.75 years, average body weight of 56.2 kg, and average body height of 172.5 cm. The testing was preceded by a 10-minute warm-up and a 400-meter swim using any stroke, followed by two repetitions of a 15-meter sprint and a 35-meter easy swim. The experiment involving hypoxic conditions was carried out over a 3-week period / 21 days in February and March 2024. The participants were randomly assigned to three groups: RG1 underwent hypoxic controlled swimming training, RG2 underwent intermittent simulated hypoxic training using the 'AltitudeTechPortable 2020' hypoxic generator, and RG3 served as a control group without any experimental intervention. The results indicate that the most significant average improvement in T1 was achieved by RG2 (+5.3%), in T2 by RG1 (+35.7%), and in T3 by RG1 (+14.3%). Based on the results, we may conclude that for performance swimmers, acute hypoxia in normoxic conditions, incorporated into swimming training in individual periods of 3 weeks and lasting 10-15 minutes per training session after warm-ups, appears to be most effective, especially when combined with intermittent hypoxia as implemented in this study, particularly for improving performance in the shortest 50-meter disciplines.
- MeSH
- Respiration MeSH
- Physical Endurance physiology MeSH
- Hypoxia * classification MeSH
- Humans MeSH
- Adolescent MeSH
- Swimming * physiology MeSH
- Athletic Performance physiology MeSH
- Endurance Training methods MeSH
- Exercise Test classification methods MeSH
- Check Tag
- Humans MeSH
- Adolescent MeSH
- Male MeSH
- Female MeSH
- Publication type
- Clinical Study MeSH
- Research Support, Non-U.S. Gov't MeSH
Svalová zdatnost představuje klíčovou složku zdraví, jejíž přesné hodnocení je zásadní. Vzhledem k vývoji v oblasti fitness narůstá potřeba zkoumat nové testovací metody, přizpůsobené specifickým podmínkám a demografickým skupinám. Tato pilotní studie se zaměřuje na korelaci mezi tradičními a inovativními testy svalové zdatnosti, s důrazem na jejich zastupitelnost u zdravé dospělé populace. Studie srovnává zavedené testy, jako jsou síla stisku ruky, kliky, leh-sedy a skok do dálky z místa, s inovativními testy, konkrétně dynamometrií pro hodnocení zad a nohou, dřepy a hodem medicinbalem. Výzkumný vzorek zahrnoval zdravé muže a ženy (n = 36) s průměrným věkem 21,3 let. Korelační analýza pomocí Pearsonova korelačního koeficientu ukázala významnou pozitivní korelaci mezi stiskem ruky a dynamometrií zad a nohou (r = 0,842, p < 0,01), což naznačuje, že tyto testy hodnotí komplementární aspekty svalové síly. Podobně hod medicinbalem vykazoval silnou korelaci se silou stisku ruky (r = 0,805, p < 0,01), což poukazuje na jeho efektivitu při hodnocení explozivní síly. Na- opak dřepy vykázaly slabou korelaci s tradičními vytrvalostními testy, jako jsou sedy-lehy (r = 0,125, p > 0,05), což naznačuje zapojení odlišných svalových skupin a aspektů vytrvalosti. Zjištěné korelace podtrhují komplexní povahu svalové zdatnosti, kde inovativní testy mohou tradiční metody jen částečně nahradit. Pro potvrzení těchto předběžných zjištění je však zapotřebí dalšího výzkumu na větších a rozmanitějších vzorcích.
Muscular fitness is a key component of health, and its accurate assessment is crucial. Due to developments in the field of fitness, there is an increasing need to explore new testing methods tailored to specific conditions and demographic groups. This pilot study focuses on the correlation between traditional and innovative muscular fitness tests, emphasizing their substitutability in a healthy adult population. The study compares established tests such as handgrip strength, push-ups, sit-ups, and standing long jump with innovative tests, specifically dynamometry for assessing the back and legs, squats, and medicine ball throws. The research sample included healthy males and females (n = 36) with an average age of 21.3 years. Correlational analysis using Pearson's correlation coefficient revealed a significant positive correlation between handgrip strength and dynamometry of the back and legs (r = 0.842, p < 0.01), suggesting that these tests assess complementary aspects of muscular strength. Similarly, the medicine ball throw showed a strong correlation with handgrip strength (r = 0.805, p < 0.01), indicating its effectiveness in assessing explosive strength. In contrast, squats showed a weak correlation with traditional endurance tests, such as sit-ups (r = 0.125, p > 0.05), indicating the involvement of different muscle groups and aspects of endurance. The identified correlations highlight the complex nature of muscular fitness, where innovative tests may only partially replace traditional methods. However, further research with larger and more diverse samples is needed to confirm these preliminary findings.
- MeSH
- Correlation of Data MeSH
- Muscle, Skeletal physiology MeSH
- Humans MeSH
- Young Adult MeSH
- Pilot Projects MeSH
- Muscle Strength * physiology MeSH
- Physical Fitness physiology MeSH
- Exercise Test * classification methods MeSH
- Check Tag
- Humans MeSH
- Young Adult MeSH
- Male MeSH
- Female MeSH
- Publication type
- Clinical Study MeSH
IMPORTANCE: Impaired exercise capacity is a cardinal manifestation of obstructive hypertrophic cardiomyopathy (HCM). The Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Obstructive HCM (SEQUOIA-HCM) is a pivotal study characterizing the treatment effect of aficamten, a next-in-class cardiac myosin inhibitor, on a comprehensive set of exercise performance and clinical measures. OBJECTIVE: To evaluate the effect of aficamten on exercise performance using cardiopulmonary exercise testing with a novel integrated measure of maximal and submaximal exercise performance and evaluate other exercise measures and clinical correlates. DESIGN, SETTING, AND PARTICIPANTS: This was a prespecified analysis from SEQUOIA-HCM, a double-blind, placebo-controlled, randomized clinical trial. Patients were recruited from 101 sites in 14 countries (North America, Europe, Israel, and China). Individuals with symptomatic obstructive HCM with objective exertional intolerance (peak oxygen uptake [pVO2] ≤90% predicted) were included in the analysis. Data were analyzed from January to March 2024. INTERVENTIONS: Randomized 1:1 to aficamten (5-20 mg daily) or matching placebo for 24 weeks. MAIN OUTCOMES AND MEASURES: The primary outcome was change from baseline to week 24 in integrated exercise performance, defined as the 2-component z score of pVO2 and ventilatory efficiency throughout exercise (minute ventilation [VE]/carbon dioxide output [VCO2] slope). Response rates for achieving clinically meaningful thresholds for change in pVO2 and correlations with clinical measures of treatment effect (health status, echocardiographic/cardiac biomarkers) were also assessed. RESULTS: Among 282 randomized patients (mean [SD] age, 59.1 [12.9] years; 115 female [40.8%], 167 male [59.2%]), 263 (93.3%) had core laboratory-validated exercise testing at baseline and week 24. Integrated composite exercise performance improved in the aficamten group (mean [SD] z score, 0.17 [0.51]) from baseline to week 24, whereas the placebo group deteriorated (mean [SD] z score, -0.19 [0.45]), yielding a placebo-corrected improvement of 0.35 (95% CI, 0.25-0.46; P <.001). Further, aficamten treatment demonstrated significant improvements in total workload, circulatory power, exercise duration, heart rate reserve, peak heart rate, ventilatory efficiency, ventilatory power, and anaerobic threshold (all P <.001). In the aficamten group, large improvements (≥3.0 mL/kg per minute) in pVO2 were more common than large reductions (32% and 2%, respectively) compared with placebo (16% and 11%, respectively). Improvements in both components of the primary outcome, pVO2 and VE/VCO2 slope throughout exercise, were significantly correlated with improvements in symptom burden and hemodynamics (all P <.05). CONCLUSIONS AND RELEVANCE: This prespecified analysis of the SEQUOIA-HCM randomized clinical trial found that aficamten treatment improved a broad range of exercise performance measures. These findings offer valuable insight into the therapeutic effects of aficamten. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT05186818.
- MeSH
- Double-Blind Method MeSH
- Cardiomyopathy, Hypertrophic * physiopathology drug therapy MeSH
- Middle Aged MeSH
- Humans MeSH
- Aged MeSH
- Oxygen Consumption physiology MeSH
- Cardiac Myosins MeSH
- Exercise Tolerance * physiology MeSH
- Exercise Test * methods MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Clinical Trial, Phase III MeSH
- Multicenter Study MeSH
- Randomized Controlled Trial MeSH
This study aims to explore: (1) the validity of post-exercise ultra-short-term heart rate variability (HRVust) after two different bouts of repeated sprint ability test (RSA), and (2) the relationship between HRVust measure and RSA performance. Twenty adolescent male futsal players voluntarily participated in this study (age: 17.65 ± 1.81 years, body height: 170.88 ± 4.98 cm, body weight: 61.78 ± 4.67 kg). The participants performed a standard RSA test (RSAstandard) and an RSA test with a 10% decrement of the best sprint time test (RSA10%decrement) on two separate occasions within a week. On both occasions, a 5-min resting electrocardiography was administered pre- and post-RSA exercise protocols. The first 30-s (HRVust30s), 60-s (HRVust60s), and 60-120-s (HRVust1-2min) were extracted and used to compare with the standard of 5-min HRV recording (HRVcriterion). The natural logarithm (ln) of the standard deviation of normal-to-normal intervals (SDNN) and root mean square of successive normal-to-normal interval differences (RMSSD) HRV indices were utilised to establish intraclass correlation coefficient (ICC2,1), coefficient of variation (%CV), and Pearson product-moment correlation (r). Results revealed the ICC values of HRVust lnSDNN (RSAstandard = 0.77-0.88; RSA10%decrement = 0.41-0.71) and lnRMSSD (RSAstandard = 0.81-0.86; RSA10%decrement = 0.57-0.82). Furthermore, significantly positive correlations between best sprint time and post-exercise HRVust indices were found in lnSDNN (r = 0.47-0.62; p < 0.05) and lnRMSSD (r = 0.45; p < 0.05). Additionally, a large CV of lnSDNN (RSAstandard = 32%-45%; RSA10%decrement = 29%-39%), lnRMSSD (RSAstandard = 50%-66%; RSA10%decrement = 48%-52%), and ratio (RSAstandard = 45%-126%; RSA10%decrement = 27%-45%) was found after the RSA protocols. In conclusion, the number of bouts of RSA exercise potentially influences the agreement of post-exercise time-domain HRVust indices to standard HRV measure.
- MeSH
- Running * physiology MeSH
- Exercise physiology MeSH
- Electrocardiography MeSH
- Humans MeSH
- Adolescent MeSH
- Athletic Performance physiology MeSH
- Heart Rate * physiology MeSH
- Exercise Test * methods MeSH
- Check Tag
- Humans MeSH
- Adolescent MeSH
- Male MeSH
- Publication type
- Journal Article MeSH
- MeSH
- Humans MeSH
- Heart Diseases MeSH
- Tilt-Table Test methods MeSH
- Exercise Test * methods MeSH
- Check Tag
- Humans MeSH
Z hlediska veřejného zdraví představuje prediabetes jeden z hlavních rizikových faktorů pro rozvoj diabetu 2. typu. Index obnovy srdeční frekvence (heart rate recovery index, HRRI) je nezávislým ukazatelem autonomních funkcí a prediktorem rozvoje kardiovaskulárních onemocnění (KVO). Cílem našeho výzkumu bylo stanovit hodnotu HRRI u jedinců s prediabetem. Metody: Do studie bylo zařazeno 400 pacientů navštěvujících kliniku kardiologie: 164 (41 %) žen a 316 (59 %) mužů. Podle Bruceho protokolu museli všichni účastníci absolvovat zátěžové EKG vyšetření na běžeckém pásu. Průběh obnovy srdeční frekvence se zaznamenává 1, 2, 3 a 5 minut po zátěžovém testu, přičemž se odečítá maximální srdeční frekvence jedince na konci testu od hodnoty naměřené během 1, 2, 3 a 5 minut zotavování. Výsledky: Obě skupiny měly podobné hodnoty délky zátěže, metabolického ekvivalentu (metabolic equivalent of task, MET), maximální srdeční frekvenci i vstupní a maximální hodnoty systolického a diastolického krevního tlaku i změny těchto dvou parametrů (p > 0,05). Hodnoty HRRI po 1, 2, 3 a 5 minutách byly vyšší u pacientů, kteří prodělali onemocnění covid-19 (p < 0,001). Závěry: Prediabetes má statisticky významný vliv na hodnotu HRRI. Prediabetes může působit na nervový i kardiovaskulární systém.
Background: Prediabetes is a major public health risk factor for type 2 diabetes. The heart rate recovery index (HRRI) shows autonomic function and predicts cardiovascular disease (CVD) independently. The objective of the research was to assess the HRRI in individuals with prediabetes. Methods: The study comprised 400 cardiology clinic patients, 164 (41% female) and 316 (59% male). The Bruce protocol required treadmill stress ECGs for all patients. After the stress test, HRRIs were collected at 1, 2, 3, and 5 minutes. HRRI is calculated by subtracting the subject's maximal exercise HR at the end of the session from HR after 1, 2, 3, and 5 minutes of recovery. Results: Both groups had a similar exercise time, METs, max. HR, baseline, max., and change in SBP and DBP (p >0.05). HRRIs were higher in COVID-19 patients than controls at 1, 2, 3, and 5 minutes (p <0.001). Conclusions: Prediabetes has a significant influence on the HRRI. Prediabetes has the potential to impact neural-cardiovascular systems.
- Keywords
- Index obnovy srdeční frekvence,
- MeSH
- Electrocardiography methods MeSH
- Cardiovascular Diseases * etiology prevention & control MeSH
- Clinical Studies as Topic methods MeSH
- Humans MeSH
- Autonomic Nervous System Diseases etiology physiopathology MeSH
- Prediabetic State * complications physiopathology MeSH
- Heart Rate * MeSH
- Exercise Test methods MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Female MeSH
- MeSH
- Cardiovascular Diseases diagnosis MeSH
- Humans MeSH
- Physical Fitness physiology MeSH
- Vital Signs MeSH
- Exercise Test * methods MeSH
- Check Tag
- Humans MeSH
- Publication type
- Review MeSH
- MeSH
- Exercise MeSH
- Diabetes Mellitus prevention & control therapy MeSH
- Cardiovascular Diseases prevention & control therapy MeSH
- Cardiac Rehabilitation MeSH
- Humans MeSH
- Kidney Diseases prevention & control therapy MeSH
- Obesity prevention & control therapy MeSH
- Osteoporosis prevention & control therapy MeSH
- Lung Diseases prevention & control therapy MeSH
- Exercise Movement Techniques MeSH
- Exercise Therapy * methods MeSH
- Exercise Test methods MeSH
- Check Tag
- Humans MeSH
- Publication type
- Review MeSH
S odvoláním na práci Yanga et al. (36) se v odborném tisku objevila doporučení jak odhalit riziko náhlé srdeční příhody pomocí jednoduchého motorického testu – schopnosti provést určitý počet kliků. Uvedená studie ukázala, že vyšší počet nepřetržitě provedených kliků (40 kliků a více) je v kohortě hasičů spojen s nižším výskytem kardiovaskulárních onemocnění (KVO) ve srovnání s těmi, kteří dosáhli méně než 10 kliků. Vyšší incidence KVO u skupiny nejméně výkonných hasičů však pravděpodobně souvisela také s dalšími zdravotními problémy a naopak, vyšší silově-vytrvalostní výkonnost v prevenci KVO není tím rozhodujícím faktorem. Navržený „klikový“ test tak může sloužit jako orientační snadno proveditelný screening k odhalení ohrožených osob.
Referring to the work of Yang et al. (36) several professional sources recommended how to detect the risk of a sudden heart attack using a simple motor test – the ability to perform a certain number of push-ups. The study showed that higher baseline push-up capacity (40 push-ups and more) in the cohort of firefighters is associated with lower incidence of cardiovascular diseases (CVD) compared with those completing less then 10 push-ups. However, the higher incidence of CVD events in the group of least powerful firefighters is probably also related to other health problems, and conversely, higher strength endurance performance in the prevention of CVD diseases is not the decisive factor. The proposed push-up test can thus serve as an orientation easy-to-perform screening to detect endangered persons.
- Keywords
- "test 40 kliků",
- MeSH
- Firefighters MeSH
- Cardiovascular Diseases * prevention & control MeSH
- Humans MeSH
- Oxygen Consumption MeSH
- Age Factors MeSH
- Exercise Test * methods MeSH
- Check Tag
- Humans MeSH